These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 11471488)
1. Status of radioimmunotherapy in the new millennium. Imam SK Cancer Biother Radiopharm; 2001 Jun; 16(3):237-56. PubMed ID: 11471488 [TBL] [Abstract][Full Text] [Related]
2. Perspectives on cancer therapy with radiolabeled monoclonal antibodies. Sharkey RM; Goldenberg DM J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy? Sautter-Bihl ML; Bihl H Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292 [TBL] [Abstract][Full Text] [Related]
9. Targeted cancer therapy using radiolabeled monoclonal antibodies. Bethge WA; Sandmaier BM Technol Cancer Res Treat; 2005 Aug; 4(4):393-405. PubMed ID: 16029058 [TBL] [Abstract][Full Text] [Related]
10. Perspectives on metals-based radioimmunotherapy (RIT): moving forward. White JM; Escorcia FE; Viola NT Theranostics; 2021; 11(13):6293-6314. PubMed ID: 33995659 [TBL] [Abstract][Full Text] [Related]
11. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model. Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507 [TBL] [Abstract][Full Text] [Related]
12. Emerging trends for radioimmunotherapy in solid tumors. Jain M; Gupta S; Kaur S; Ponnusamy MP; Batra SK Cancer Biother Radiopharm; 2013 Nov; 28(9):639-50. PubMed ID: 23844555 [TBL] [Abstract][Full Text] [Related]
13. The new golden era for radioimmunotherapy: not just for lymphomas anymore. Tomblyn MB; Katin MJ; Wallner PE Cancer Control; 2013 Jan; 20(1):60-71. PubMed ID: 23302908 [TBL] [Abstract][Full Text] [Related]